<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39426933</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Influenza B/Yamagata cannot currently be declared extinct.</ArticleTitle><Pagination><StartPage>126450</StartPage><MedlinePgn>126450</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2024.126450</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(24)01132-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>MacIntyre</LastName><ForeName>Chandini R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Biosecurity Program, The Kirby Institute, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia; College of Public Service &amp; Community Solutions, Arizona State University, Tempe, AZ, USA. Electronic address: r.macintyre@unsw.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Zubair</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Biosecurity Program, The Kirby Institute, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moa</LastName><ForeName>Aye</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biosecurity Program, The Kirby Institute, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Declaration of competing interest C Raina MacIntyre receives funding from NHMRC and MRFF. She is currently receiving funding from Sanofi for research on influenza and pertussis. She is on the WHO COVID-19 Vaccine Composition Technical Advisory Group (2021-2024) and the WHO SAGE Monkeypox and Smallpox ad hoc working group. She is also an associate editor of Vaccine.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>21</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39426933</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2024.126450</ArticleId><ArticleId IdType="pii">S0264-410X(24)01132-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>